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Abstract
Objective: To report mid-term results of stent-graft (SG) implantation in acute thoracic aortic rupture as alternative to conventional open
surgery with its associated high morbidity and mortality rates. Methods: Out of a series of 69 patients undergoing thoracic aortic SG
implantation since 1998, 24 (mean age 57 ^ 19 years, range 20–85-years-old) patients were treated on an emergency basis for hemorrhage
control. The indication for SG placement was acute traumatic aortic rupture in 15 patients, type B dissection with contained rupture in 3
patients, penetrating aortic ulcer with periaortic hematoma in 3 patients, and thoracic aortic aneurysm rupture in 3 patients. Preoperative
assessment was done by computed tomography (CT) scanning and echography. Patients were treated in the angiography suite by
implantation of Excluder ðn ¼ 18Þ; Talent ðn ¼ 4Þ; Corvita ðn ¼ 1Þ; and Vanguard ðn ¼ 1Þ self-expanding grafts. Local anesthesia was the
most frequently used anaesthesiologic technique. Results: Technical success rate of SG deployment was 100%. The early postoperative
mortality was 12.5% (3 of 24). One patient suffered temporary paraplegia (4%). There was no intervention-related mortality during the mean
follow-up of 34.1 months. Two secondary endoleaks were successfully treated with additional SG placement at 2 and 12 months
postoperative, respectively. Conclusions: Emergency SG repair to control hemorrhage in patients with an acute thoracic aortic rupture is a
less-invasive attractive and rational treatment option, especially if associated lesions or co-morbidity may interfere with the surgical
outcome. Long-term follow-up results will be helpful to clarify procedure durability bounded by material failure and postoperative aneurysm
or aortic wall remodelling.
q 2004 Elsevier B.V. All rights reserved.
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1. Introduction
Acute thoracic rupture, whether due to a deceleration
trauma of the aorta, thoracic aortic aneurysm, aortic type B
dissection or a penetrating ulcus of the aorta pose a major
risk of death to the patient and remain a therapeutic
challenge. Hemorrhage control and prevention of fatal
bleeding are primary treatment goals in this medical
emergency. Seventy to 90% of patients with acute aortic
rupture following blunt trauma die at the scene of injury or
before reaching the operating room [1–3]. Those who
survive usually have a contained aortic rupture and require
mostly emergent intervention to control mediastinal hemor-
rhage. Early postoperative mortality of surgically treated
patients is estimated to range from 7.7 [4] to 28% [5].
Ruptured thoracic aortic aneurysm, type B aortic dissection,
penetrating aortic ulcer is more common in older patients
and have a high early postoperative mortality, ranging from
24 [6] to 42.1% [7]. In this subgroup of elderly patients,
mortality has been reported to be 50%, when operation was
performed on the emergency basis [8].
An increasing number of reports on successful endovas-
cular treatment of the thoracic aorta lesions by stent-grafting
(SG) has been published so far [9–11]. Our report presents
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results of the medium-term follow-up of 24 patients treated
with SG for hemorrhage control in ruptured thoracic aorta.
2. Methods
2.1. Patients
Between February 1998 and April 2003, 69 patients
received endoaortic SGs in the descending thoracic aorta at
our institution. Out of this group, 24 patients presented an
acute thoracic aortic rupture and had to be treated on the
emergency basis for hemorrhage control. Nineteen men
(79.2%) and 5 women (20.8%) ranged in age from 20 to 85
years (mean (^SD), 57 ^ 19 years). The underlying aortic
disease were traumatic aortic rupture (62.5%) in 15 patients,
penetrating aortic ulcer with periaortic hematoma in
3 patients, ruptured aortic type B dissection in three, and
ruptured thoracic aortic aneurysm (each 12.5%) in three.
Median delay between the event and the procedure was
2 days. This seemingly long delay is mostly due to very few
hemodynamically stable patients who underwent SG
placement only after prolonged recovery from associated
life-threatening lesions. However, in the vast majority of
cases the procedure was done either on the same or the event
following day and very often the procedure had to be
performed on hemodynamically unstable patients. The
preoperative patient characteristics and comorbidities are
shown in Table 1.
Preinterventional diagnostic work-up included chest
X-ray, spiral contrast-enhanced computing tomography,
and echography in all patients. At the time of SG insertion,
intravascular ultrasound (IVUS) examination was per-
formed in six cases in addition to calibrated catheter
predeployment aortography performed by all the
procedures.
In 15 trauma patients, the location of primary tear at
the aortic isthmus ranged from 0.5 to 3 cm distally of the
left subclavian artery origin (mean 1.9 ^ 0.5 cm) and
consisted of contained circular ðn ¼ 1Þ; semi-circum-
ferential ðn ¼ 5Þ transsection, and intimal tear with
localized dissection ðn ¼ 9Þ: In 3 patients with type B
aortic dissection, the primary entry-tear location was
2–4 cm below the left subclavian artery origin with the
dissection extended downward. Ruptured thoracic aortic
aneurysms, ranging in diameter from 5.5 to 8.0 cm, were
located in distal ðn ¼ 2Þ or extended from middle to distal
portion of the thoracic aorta ðn ¼ 1Þ: Penetrating aortic
ulcers were found in the mid ðn ¼ 1Þ or distal ðn ¼ 2Þ
portion of the thoracic aorta.
Table 1
Preoperative characteristic of 24 patients with aortic rupture undergoing stent-graft placement
No. Age Sex Type of rupture Comorbidities // preoperative state
1 65 M Traum Aort Rupt HTN // CCtr, hemopneumothorax, lung cont, facial bone/rib Fr
2 51 M Traum Aort Rupt COPD // CCTr, rib Fr, aneurysma spurium
3 24 M Traum Aort Rupt CCTr, hemothorax, myocard/lung cont, liver/kidney lac, facial bone/Rib
/UE Fr
4 65 M Traum Aort Rupt CCTr, hemopneumothorax, lung cont, liver lac, skull base/rib/bilat UE Fr
5 80 F Penetr Aort Ulcus HTN, CAD, PAD // periaortic hematoma
6 41 M Traum Aort Rupt Multiple UE Fr, aneurysma spurium
7 20 M Traum Aort Rupt CCTr, Hemothorax, myocard/lung cont, liver/kidney lac, pelvic/ vertebr Fr
8 68 M Traum Aort Rupt Mediastinal hematoma, hemopneumothorax, lung cont, rib Fr
9 81 M Penetr Aort Ulcus HTN, CAD, PAD, COPD // hemothorax
10 70 M Ruptured TAA htn, copd // hemothorax
11 75 M Rupt B-Diss Periaortic and mediastinal hematoma, hemothorax
12 48 M Traum Aort Rupt Hemothorax, rib/carpal Fr
13 46 M Traum Aort Rupt CCTr, Liver lac, lung cont, rib/pelvic/le fr, contained aortic rupture
14 70 M Penetr Aort Ulcus HTN, CAD, PAD // hemothorax
15 85 F Rupt B-Diss HTN, renal failure // mediastinal hematoma, hemothorax
16 54 M Traum Aort Rupt Hemopneumothorax, lung cont, liver/kidney lac, rib/lumbal/vertebr Fr
17 44 M Traum Aort Rupt HTN, DM // CCTr, hemothorax, facial bone/rib/pelvic/LE Fr
18 46 M Traum Aort Rupt Hemopneumothorax, facial bone/rib/bilat LE Fr
19 74 F Ruptured TAA HTN, severe COPD, history of CVA // hemothorax
20 22 M Traum Aort Rupt Hemothorax, lung cont, liver/spleen/kidney Lac, rib/pelvic/LE Fr
21 75 F Rupt B-Diss HTN, CAD, PAD, DM, infrarenal AAA repair 12 years prior // hemothorax
22 41 M Traum Aort Rupt CCTr, hemopneumothorax, lung cont, spleen lac, rib/mult LE Fr
23 38 M Traum Aort Rupt HTN // hemothorax, myocard/lung cont, facial bone/rib/bilateral UE Fr
24 76 F Ruptured TAA HTN, PAD, ARF, chronic mesenteric vascular occlusion // hemothorax
TAA, thoracic aortic aneurysm; HTN, arterial hypertension; CAD, coronary artery disease; PAD, peripheral arterial disease; COPD, chronic obstructive
pulmonary disease; DM, diabetes mellitus; CVA, history of cerebro-vascular accident; ARF, acute renal failure; CCTr, craniocerebral trauma; Fr, fracture; UE,
upper extremity; LE, lower extremity; Lac, laceration; Cont, contusion; B-Diss, Type B aortic dissection.
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2.2. Stent-grafts
Patients were treated by implantation of commercially
available standard self-expanding endovascular SGs:
Excluder Endograft (Gore and Assoc., Flagstaff, AZ)
ðn ¼ 18Þ; Talent Stent-Graft (Medtronic, Sunnyvale, CA)
ðn ¼ 4Þ; Corvita Endovascular Graft (Schneider Corp./
Boston Scientific Corp., Natick, MA) ðn ¼ 1Þ; and
Vanguard Stent-Graft (Boston Scientific Corp., Natick,
MA) ðn ¼ 1Þ: The SGs used for the repairs of type III
endoleak in patient 3 (12 months after the first
procedure) and of aneurysm at the distal end of the
prosthesis in patient 5 (2 months after the first procedure)
were Talent and Vanguard, respectively (Table 2).
The decisions on SG dimensions were based on
measurements by contrast enhanced volumetric computed
tomography (CT) and quantitative aortography with a
calibrated catheter. The endovascular prostheses were
oversized by 10–15% relative to the aortic diameter.
The mean diameter of the SGs was 31 ^ 5 mm (range
20–40 mm) and their mean length was 12.8 ^ 4.7 cm
(range 5–20 cm).
2.3. Procedure
All procedures were performed in the angiography
suite with its capabilities for high-quality imaging in
multiple projections. Patients were positioned supine,
prepped and draped for primarily intended femoral
arteriotomy, allowing also potential retroperitoneal iliac
artery approach. In 13 cases local anesthesia was used.
General anesthesia was performed in the nine trauma
patients who had been already intubated prior to the
procedure and in two cases to enable mandatory retro-
peritoneal access. In the majority of cases, the right
common femoral artery (CFA) was surgically exposed
and used for puncture, followed by guidewire and sheath
(range 22–28-French) placement. Considering the indi-
vidual bleeding risk, especially in polytrauma patients, no
heparin at all ðn ¼ 3Þ; or maximum 100 U/kg intravenous
heparin was administered and completely reversed after
SG delivery. Aortography was done with a 5- or 6-
French calibrated angiographic pigtail catheter advanced
through either the left brachial artery ðn ¼ 8Þ or the
contraleteral CFA into the ascending aorta. In all cases, it
was possible to accurately identify the primary entry tear
site. Under fluoroscopic control, and additional IVUS in
6 patients, SG was delivered through the sheath and
deployed in the thoracic aorta. Final angiogram was
made in each case to confirm the correct position of the
prosthesis and exclusion of the lesion.
Following the monitoring in the intensive care unit
(ICU), patients underwent spiral CT and in selected cases
angiography prior to discharge. All patients underwent strict
Table 2
Implanted stent-grafts and postoperative follow-up of 24 patients
No. Age Stent-graft type (Size in mm) Follow-up (months) Complications/follow-up
1 65 Excluder 34 £ 120 45 No complications, nearly 4 years after interv died due to a lung cancer
2 51 Excluder 31 £ 100 60 No complications, alive and well
3 24 Corvita 20 £ 80 60 12 Months after interv talent 24 £ 63 to fix endoleak III, alive and well
4 65 Talent 36 £ 120 56 No complications, alive and well
5 80 Vanguard 26 £ 50 54 2 Months after interv Vanguard 26 £ 50 to fix distal aneurysm, alive and
well
6 41 Excluder 30 £ 70 48 No complications, alive and well
7 20 Excluder 28 £ 74 43 No complications, alive and well
8 68 Talent 36 £ 130 Died Died 1 day after intervention due to intractable bleeding
9 81 Excluder 34 £ 200 37 No complications, alive and well
10 70 Excluder 34 £ 200 36 Postinterv Paraplegia Th 4, resumed ambulation after 5 months, alive and
well
11 75 Excluder 34 £ 150 36 No complications, alive and well
12 48 Excluder 28 £ 100 33 No complications, alive and well
13 46 Excluder 28 £ 100 32 No complications, alive and well
14 70 Excluder 40 £ 200 32 No complications, alive and well
15 85 Excluder 24 £ 200 30 No complications, alive and well
16 54 Excluder 34 £ 150 28 No complications, alive and well
17 44 Excluder 28 £ 100 27 No complications, alive and well
18 46 Excluder 28 £ 100 21 No complications, alive and well
19 74 Excluder 34 £ 150 13 13 months after interv died due to a cardiac arrest
20 22 Excluder 28 £ 150 12 No complications, alive and well
21 75 Excluder 40 £ 200 Died Died 5 days after interv due to intestinal infarction (non-embolic cause)
22 41 Excluder 31 £ 150 7 No complications, alive and well
23 38 Talent 28 £ 60 7 No complications, alive and well
24 76 Talent 28 £ 116 Died Died 1day after interv due to mesenterial infarction (thromboembolic
cause)
Interv, intervention.
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follow-up protocol comprising of a contrast enhanced spiral
CT and a complete clinical examination at 6 and 12 months
after the SG implantation and then yearly thereafter. During
these follow-up visits, quality of life was measured based on
functional and physical status assessment and global health-
related quality of life questionnaire.
3. Results
The endovascular SG deployment within the true lumen
of the aorta had an immediate technical success of 100%.
The origin of the left suclavian artery was overstented
partially in 5 patients; however, subclavian artery bypass
was not needed in any of the cases. Series of images
(patient 15, Table 1) depicted in Figs. 1 and 2 shows
successful SG of the ruptured type B dissection. In one
patient, 12 months post implantation a persisting type III
endoleak caused by material failure occurred (the SG is not
available anymore). This has been treated by an additional
SG implantation. In another 80-year-old patient, an
aneurysm formed at the distal end of the prosthesis and
had to be excluded by an additional SG 2 months after
primary intervention. Temporary paraplegia occurred in
one patient who resumed ambulation after 5 months. Early
mortality was 12.5% (3/24 patients) with various causes.
One 68-year-old patient with a semi-circumferential
traumatic rupture of the aorta died 12 h after the SG
placement due to a severe and intractable bleeding. The
autopsy suggested an undetected incomplete proximal
sealing as a cause of bleeding. Another 75-year-old
polymorbid NYHA IV patient (Table 1) with a severe
arteriosclerosis and a history of infrarenal abdominal aortic
aneurysm (AAA) repair 12 years prior to the ruptured type
B dissection of the aorta developed postinterventionally a
mesenteric infarction. This was treated with a partial
resection of the small bowel, however, patient died from a
septic shock and bilateral pneumonia in the ICU. Post-
mortem examination could not identify any thrombo-
embolic material or dissection membrane in the mesenteric
vessels. One further patient, a 76-year-old patient with
ruptured thoracic aortic aneurysm, generalized arterio-
sclerosis, and preexisting chronic occlusion of the celiac
trunk, died 1 day postinterventionally following a mural
thrombus dislodgement in the aorta and the thromboem-
bolic occlusion of the superior mesenteric artery (Table 2).
Fig. 1. Periaortic hematoma with left-sided hemothorax (A); dissection and aortic rupture at the distal arch level (B); huge kinking of the distal thoracic aorta
(C); and disease-free infrarenal aorta (D).
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The overall mean ICU stay was 3.5 days. However,
excluding polytrauma patients, ICU stay averaged 1.5 days.
The overall mean hospital stay was 15 days, also prolonged
due to multiple associated injuries in trauma patients. After
discharge from the hospital all 21 survivors were subjected
to a strict follow-up protocol consisting of CT scans and
complete physical examination at 6 and 12 months post
intervenetion and then yearly thereafter. Postinterventional
CT scans showed a complete exclusion of the aortic rupture
locations and no stent migration was documented over the
follow-up period. Ruptured aortic type B dissection in one
patient showed complete thrombosis of the false lumen. In
another asymptomatic patient with ruptured type B dissec-
tion, a partial thrombosis of the false lumen with no need for
further intervention was observed. No further procedure
related complications occurred and in no case was aortic
reoperation needed.
Final follow-up for this study was determined in June
2003 and was 100% complete. The mean follow-up period
was 34.1 ^ 15.9 months (ranging from 6.6 to 60.0 months).
All patients have found to enjoy an excellent quality of life.
An actuarial survival curve is shown in Fig. 3.
4. Discussion
Current stand on the most efficient treatment of acute
aortic rupture remains still a controversial issue. Associated
lesions in polytrauma patients with traumatic rupture of
the aorta and a wide spectrum of comorbidities in the high-
risk patients with ruptured thoracic aortic aneurysm or
ruptured type B aortic dissection make open surgery a
therapy with a relatively high postoperative morbidity and
mortality rates.
The natural course of traumatic aortic injury has been
reported to be very poor, with an initial survival rate ranging
from 10 to 30%. In-hospital mortality rates increases from
32% on the first day, to 61% within the first week, and 74%
after 2 weeks [1]. When survived without intervention, more
than 30% of chronic traumatic thoracic aortic aneurysms
were ruptured in the late phase [12]. Actually, there is no
study that allows to differentiate intimal injuries that will
progress to hemorrhage from those with a more benign
course. On the other hand, those patients undergoing
surgical treatment have an early postoperative mortality
rate ranging from 7.7 [4] to 28% [5]. The series of 263 aortic
blunt trauma patients published by Attar et al. [13], reported
a 24% operative mortality rate and a 13% incidence of
paraplegia. Timing of surgery in these polytrauma patients
is usually complicated by associated lesions, where
necessary heparinization would exacerbate early mortality
rate. In addition, aortic cross-clamping might cause
increased intracranial pressure and increase the risk of
postoperative paraplegia, especially in patients with cranio-
cerebral trauma [14]. In our subgroup of 15 patients with
traumatic aortic ruptures, there was one early postoperative
death resulting in an early mortality rate of 6.7%.
Following the excellent results of our earlier experience in
SG of traumatic aortic rupture [15], we expanded the
indication for hemorrhage control to any cases of acute aortic
rupture, as for instance acute type B aortic dissection,
penetrating aortic ulcer, and thoracic aortic aneurysm. This
meant including older and sicker patients with much higher
Fig. 2. Stent-graft procedure. First step consisting of angiography with calibrated catheter, located within the true lumen. Note the second pigtail catheter
introduced through the left brachial artery (A); gore stent-graft deployed with overstenting of the left subclavian artery origin (B); and post-procedural
Angiography CT scan reconstruction showing a complete sealing and thrombosis of the false lumen (C).
Fig. 3. Acturial survival curve. Time scale is based on number of months.
Number of patients remaining at risk for main intervals analyzed are
depicted above the time scale.
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preoperative risk factor index and also explains higher overall
mortality in the present study than in our first published series,
consisting only of traumatic aortic rupture patients.
Severely diseased and atherosclerotic aorta in elderly
patients, presenting whether ruptured thoracic aortic
aneurysm or ruptured type B aortic dissection remains
unchanged a major therapeutic challenge to clinicians, no
matter which approach would be chosen. In this high-risk
polymorbid group of elderly patients, endovascular
approach has been demonstrated to be readily justifiable.
Several groups published encouraging results after implan-
tating endografts electively in patients with thoracic aortic
aneurysms and type B dissections [9,10,16–22]. Conven-
tional open surgery, using cardiopulmonary bypass, has a
high mortality rate, and ranges from 17 to 29% in elective
cases, but can be as high as 50%, when surgery is performed
on an urgent basis [7,23,24]. Two of the 9 patients treated
for a non-traumatic descending aortic rupture died within 30
days (22% early mortality rate). This is clearly below the
expected mortality rate of the surgical approach.
Mortality rate of the 24 patients treated by SG showed a
lower mortality as it would be expected from the
preoperative EuroSCORE [25]. The group of patients
suffering from traumatic aortic rupture ðn ¼ 15Þ presented
a preoperative EuroSCORE of 6.7 ^ 1.9. This would
predict a calculated mortality rate of 9.5 ^ 4.3%. Patients
with ruptured thoracic aorta, penetrating aortic ulcer or
ruptured type B dissection (overall n ¼ 9) have shown a
much higher EuroSCORE due to associated comorbidities
and higher age—12.1 ^ 1.6 with calculated mortality rate
of 34.0 ^ 12.4%.
As in most of the cases, SG implantation can be
performed through the femoral arteries, the procedure can
be performed under local anesthesia. This has several
advantages especially in the elderly and/or polymorbid
population suffering from coronary artery-, cerebral-,
mesenteric-, renal arteries disease. Pulmonary complication
rate is reduced, as patients do not require an intubation/
ventilation. Moreover, hypotension caused by the induction
of general anesthesia is minimized, which is detrimental
especially in multifocally atherosclerotic diseased patients.
Both, open surgery and endoluminal treatment of
thoracic aortic lesions bears a significant risk of post-
procedural paraplegia. Especially, intra-operative hypoten-
sion and cross-clamp time longer than 30 min significantly
increases postoperative paraplegia incidence [13,14]. In a
study comprising 263 patients with traumatic aortic rupture,
Attar et al. [13] reports a 13% incidence of postoperative
paraplegia after an open graft repair and von Oppell et al. in
their 20-year meta-analysis on traumatic aortic rupture
report a 11.1% incidence. Paraplegia following emergent
open repair of thoracic aortic aneurysm can be as high as
22% [6]. On the other hand, endoluminal SG of the
descending thoracic aorta is associated with a post-
interventional paraplegia rate ranging from 0 to 7%
[9 – 11,17,19,20]. In the present study, only one
post-interventional paraplegia occurred (1/24, 4%) and
resolved within 5 months. Retrospectively, the length of
recovery could have been possibly shortened, had cere-
brospinal fluid drainage been instituted in the very early
postoperative phase.
Secondary endoleaks after SG remains an issue. In the
present study, two secondary endoleaks occurred. One
patient presenting a coating failure was treated by
implantation of an additional SG 12 months after the
primary procedure. Another patient needed 2 months after
the first procedure a distal SG extension to treat an
attachment endoleak. No other reinterventions were needed
and no graft migration was noted on any of the patients
during the follow-up period.
In conclusion, emergent SG for hemorrhage control in
acute thoracic aortic rupture is a safe and less-invasive
alternative to the open graft repair. In addition to a shorter
procedure time and local anesthesia benefits, it avoids the
necessity of extracorporeal circulation and aortic cross-
clamping with its risk of paraplegia and feared side effects
of systemic heparinization. Mid-term results are so far
excellent, however, long-term results are required.
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Appendix A. Conference discussion
Dr A. Graffigna (Trento, Italy): I would like to know from you, how do
you deal with those cases of traumatic aortic rupture where rupture is very
close to a subclavian artery? How do you face the riddle whether to cover
the subclavian artery with the stent or to address these patients through
traditional surgery?
Dr Melnitchouk: Well, following blunt injury to the aorta, the aorta
usually disrupts where the ligamentum arteriosum attaches to the aorta at
the aortic isthmus and it is approximately 2 cm below. We had 1.9-cm
median value of where the disruption was. And of course, it is very close to
the subclavian artery.
But in the cases where disruption is very close to the subclavian artery,
it can be safely overstented, except for the cases where a patient has a
LIMA to LAD graft, then you would have to perform the carotid subclavian
bypass.
Also you would have to monitor the blood pressure in the left arm. If the
blood pressure after the overstenting of the subclavian artery is below 50,
then you would have to go ahead and do the carotid subclavian bypass. We
had some cases that had to be overstented, but in none of the cases there was
a steal syndrome in the left arm.
Dr J. Bachet (Paris, France): I was a little surprised that compared to
surgery, your results are not really convincing. I mean, they are, but not as I
expected they should be. That’s the first comment.
And second question: what is the policy of your group concerning
patients with acute traumatic rupture who are not threatened immediately
from exsanguination? Do you still send them to surgery or do you switch
systematically to the endoprosthesis treatment?
Dr Melnitchouk: Well, we had very good experience with stent-graft
placement for traumatic aortic rupture. And for the high-risk patients with
severe comorbidities, high age and very high preoperative EUROScore, I
think endovascular approach to treat these aortic lesions is very elegant and
a very good way. High-risk patients tend to be sick and they tend to go a
certain direction. No matter what you do, you decide to operate on them or
you decide to stent them, they are just high-risk patients and there is quite a
high mortality in these patients.
Dr M. Turina (Zurich, Switzerland): If I may add, the present policy
due to this one death case, which was totally surprising to us—because
patient had a good EAP deployment and good sealing of the rupture, has
been changed. Every patient with a substantial periaortic hematoma will go
to surgery, unless there is a major contraindication like a severe cerebral
trauma, liver rupture or something similar. Small periaortic hematomas,
intimal lesions and flaps receive EAP. And the policy about the immediate
surgery is governed by other organ trauma and by the cerebral state of these
patients, so that we will be waiting for a day or two if there is a brain edema
or similar like this.
Dr S. Aziz (Takoma Park, Maryland, USA): We actually had a case of
traumatic aortic tear in the usual location near the left subclavian artery.
The patient also had multiple other injuries to the head and abdomen. He
was not an open candidate for open surgical repair. We were able to use the
Gore thoracic Excluder stent. After placement of the device we noted that
we still had a leak from the proximal side. So we put another stent within
the stent. This covered the tear and there was no evidence of further
leakage.
Dr Melnitchouk: Yes. Especially earlier grafts were of not very good
quality, but we have very good experience with the next generation of stent-
grafts.
Dr M. Krason (Zabrze, Poland): We have had about 15 cases in total
series of stent-grafting of descending thoracic aorta dissections and
aneurysm. And we have closed successfully in five or six cases subclavian
artery with no surgical treatment afterwards and the patients were doing
successfully quite well with no ischemia.
Dr Melnitchouk: We had the same experience.
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